Profitability
Weight: 20%
C+
62
- 5yr Avg ROIC 7.1%
- Operating Margin Trend +4.95 pp/yr
RPRX
Royalty Pharma plc
AlphaQuality composite grade, weighted for stable earnings power businesses.
Capital Efficiency
Weight: 15%
D+
41
- 5yr Avg ROE 10.6%
- 5yr Share-Count CAGR 7.8%
Growth Quality
Weight: 15%
D+
43
- 5yr Revenue CAGR 1.0%
- 5yr EPS CAGR 4.8%
- Revenue-Growth Years (5) 3/5
Cash Generation
Weight: 15%
A-
84
- 5yr FCF Margin 107.6%
- 5yr FCF/NI Conversion 12.48x
Balance Sheet
Weight: 20%
D
37
- Net Debt / EBITDA 5.08x
- Interest Coverage (EBIT/Int) 5.30x
- Altman Z-Score 2.05
Stability
Weight: 15%
D+
42
- EPS Volatility (σ/μ) 0.80
- Piotroski F-Score 7
- Negative-Revenue Years (5) 2/5
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.2 of 2 gurus held; 1 added; 1 trimmed.
- Holders
- 2
- Avg Δ position
- +12.8%
- New buys
- 0
- Full exits
- 0